ViaDerma, Inc. (VDRM)
OTCMKTS · Delayed Price · Currency is USD
0.0016
-0.0001 (-5.88%)
Aug 4, 2025, 3:51 PM EDT
Despegar.com Market Cap
ViaDerma has a market cap or net worth of $1.97 million as of August 4, 2025. Its market cap has decreased by -68.63% in one year.
Market Cap
1.97M
Enterprise Value
n/a
Revenue
44.69K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 6, 2009, ViaDerma's market cap has decreased from 30.60M to 1.97M, a decrease of -93.55%. That is a compound annual growth rate of -15.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 1.97M | -78.38% |
| Dec 31, 2024 | 9.13M | -30.19% |
| Dec 29, 2023 | 13.08M | 114.62% |
| Dec 30, 2022 | 6.09M | -28.79% |
| Dec 31, 2021 | 8.56M | 452.93% |
| Dec 31, 2020 | 1.55M | 44.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| CytoDyn | 366.82M |